CAMBRIDGE, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will
webcast its presentations at the JPMorgan Small/Mid Cap Conference on
Monday, November 13, 2006 at 10:15 a.m. EST; the Credit Suisse Phoenix
Healthcare Conference on Thursday, November 16, 2006 at 12:00 p.m. MST
(2:00 p.m. EST); and at the Piper Jaffray 18th Annual Health Care
Conference on Wednesday, November 29, 2006 at 1:30 p.m. EST.
Each presentation will be webcast live and may be accessed under the
"Investors" tab at http://www.vrtx.com. A replay of the webcasts will also
be available on Vertex's website for two weeks following the presentations.
To ensure a timely connection, it is recommended that users register at
least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with
GlaxoSmithKline. Lexiva is a registered trademark of the GlaxoSmithKline
group of companies. Vertex's press releases are available at
http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com/
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex, +1-617-444- 6755
|
